Cargando…
New-onset crescent IgA nephropathy following the CoronaVac vaccine: A case report
RATIONALE: Although coronavirus disease 2019 (COVID-19) remains a global threat, administering effective and safe vaccines is currently the most promising strategy to curb the ongoing pandemic and decrease the number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. However...
Autores principales: | Ran, Enrong, Wang, Maohe, Wang, Yanmei, Liu, Rongzhi, Yi, Yanxia, Liu, Yuanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388006/ https://www.ncbi.nlm.nih.gov/pubmed/35984162 http://dx.doi.org/10.1097/MD.0000000000030066 |
Ejemplares similares
-
IgA antibody dynamics in healthcare workers after CoronaVac® vaccination and heterologous Comirnaty® booster dose
por: Bochnia-Bueno, Lucas, et al.
Publicado: (2023) -
Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022) -
CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk
por: Calil, Valdenise Martins Laurindo Tuma, et al.
Publicado: (2021) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023) -
Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)